Skip to main content
. 2017 Aug 21;17(3):231–237. doi: 10.2463/mrms.mp.2016-0149

Table 1.

Baseline characteristics of two groups

Patient and clinical characteristics OE with benign mural nodules EAOC P value
Number 42 40
Pathology Blood clot (n = 33)
Atypical feature (n = 3)
Adenofibroma (n = 2)
Fibrothecoma (n = 2)
Papillary proliferation (n = 2)
Clear cell carcinoma (n = 22), Endometrioid carcinoma (n = 11)
Serous carcinoma (n = 3), Mucinous carcinoma (n = 2), Undifferentiated carcinoma (n = 1), Transitional carcinoma (n = 1)
FIGO stage I (n = 35), II (n = 0), III (n = 3),IV (n = 2)
Age at diagnosis, mean ± SD 39.1 ± 10.3 54.3 ± 8.9 <0.001
Median (range) 39 (26 – 68) 52 (39 – 75)
Nulliparous n (%) 21 (50) 16 (40) 0.55
Premenopause n (%) 38 (90.5) 14 (35) <0.001
CA125 (IU/l)
Mean ± SD 86.8 ± 99.4 992.5 ± 3166 0.07
Median (range) 34.5 (6 – 437) 60.5 (7 – 15451)
The size of a cyst (cm)*
Mean ± SD 6.6 ± 3.2 10.9 ± 3.9 <0.001
Median (range) 5.9 (2.5 – 19.1) 10.4 (2.9 – 19)
Height (cm), mean ± SD 0.7 ± 0.3 3.7 ± 2.3 <0.001
Median (range) 0.7 (0.2 – 1.6) 3.3 (1 – 10.8)
Width (cm), mean ± SD 1.5 ± 1.0 3.5 ± 2.3
Median (range) 1.2 (0.5 – 4.9) 2.9 (0.9 – 10.6) <0.001
HWR of mural nodule,
Mean ± SD 0.5 ± 0.2 1.1 ± 0.2 <0.001
Median (range) 0.56 (0.20 – 0.68) 1.09 (0.47 – 1.63)
Location (%)
  AUQ 2 (4.8) 9 (22.5) <0.001
  ALQ 2 (4.8) 16 (40)
  PUQ 8 (19) 3 (7.5)
  PLQ 30 (71.4) 12 (30)
Signal intensity of cystic part (%)
  On T1WI
    Low 0 (0) 13 (32.5) <0.001
    Intermediate 4 (9.5) 13 (32.5)
    High 38 (90.5) 14 (35)
  On T2WI
    Low 3 (7.1) 0 (0) 0.009
    Intermediate 13 (31) 3 (7.5)
    High 26 (61.9) 37 (92.5)
Shading n (%) 27 (64.3) 7 (14) <0.01
*

Maximum diameter of the cyst. ALQ, anterior lower quadrant; AUQ, anterior upper quadrant; FIGO, Federation of Gynecology and Obstetrics; PLQ, posterior lower quadrant; PUQ, posterior upper quadrant; SD, standard deviation; T1WI, T1weighted image; T2WI, T2weighted image.